Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB00273_nanopub.RAYiFeNJaojI5wqXvUYXsyljhmRzFmHFtPTsUCYjTqkQk#assertion>. }
Showing items 1 to 29 of
29
with 100 items per page.
- drugbank:DB00273 type drugbank_vocabulary:Drug assertion.
- drugbank:DB00273 label "Topiramate [drugbank:DB00273]" assertion.
- drugbank:DB00273 seeAlso DB00273 assertion.
- drugbank:DB00273 seeAlso topiramate.html assertion.
- drugbank:DB00273 seeAlso top1541.shtml assertion.
- drugbank:DB00273 seeAlso topiram.htm assertion.
- drugbank:DB00273 identifier "drugbank:DB00273" assertion.
- drugbank:DB00273 description "Topiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics, a division of Johnson & Johnson. It is used to treat epilepsy in both children and adults. In children it is also indicated for treatment of Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). It is also Food and Drug Administration (FDA) approved for, and now most frequently prescribed for, the prevention of migraines. [Wikipedia]. A combination product containing phentermine and topiramate extended-release called QSYMIA® is indicated for the management of obesity. On August 2013, an extended released formulation, marketed as Trokendi XR has been approved for the management of partial onset, tonic-clonic, and Lennox-Gastaut Syndrome seizures." assertion.
- drugbank:DB00273 title "Topiramate" assertion.
- drugbank:DB00273 bio2rdf_vocabulary:identifier "DB00273" assertion.
- drugbank:DB00273 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB00273 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB00273" assertion.
- drugbank:DB00273 bio2rdf_vocabulary:x-identifiers.org DB00273 assertion.
- drugbank:DB00273 drugbank_vocabulary:drugbank-id "APRD00237" assertion.
- drugbank:DB00273 drugbank_vocabulary:drugbank-id "DB00273" assertion.
- drugbank:DB00273 drugbank_vocabulary:x-cas cas:97240-79-4 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-chemspider chemspider:4447672 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-pubchemcompound pubchem.compound:5284627 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:46508334 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-ahfs ahfs:28:12.92 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-atc atc:N03AX11 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-chebi chebi:63631 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-dpd dpd:2239908 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-kegg kegg:C07502 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-kegg kegg:D00537 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-pharmgkb pharmgkb:PA451728 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-wikipedia wikipedia:Topiramate assertion.
- drugbank:DB00273 drugbank_vocabulary:x-bindingdb bindingdb:10887 assertion.
- drugbank:DB00273 drugbank_vocabulary:x-ndc ndc:0904-6016-04 assertion.